Literature DB >> 2530755

Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain.

S X Xu, L P Yu, Y R Han, Y Chen, G Z Jin.   

Abstract

The effects of 12 tetrahydroprotoberberines (THPBs) on D1 and D2 receptors labelled with [3H]DA, [3H]Sch-23390 and [3H]spiperone were evaluated. Their effects on the activity of adenylate cyclase stimulated with DA 40 mumols/L were also assessed. All of the l-THPBs tested behaved as DA receptor antagonists with preferential affinity toward the D1 receptors. Among them, l-stepholidine (l-SPD), a THPB analog with 2 hydroxy groups at the C2 and C10 positions, was the most potent. Its affinity toward D1 receptors was 4-7 times higher than that toward D2 receptors. The results suggest that the hydroxy groups in l-THPBs are very important factors in determining the affinity to DA receptors. Moreover, d-tetrahydropalmatine (d-THP), a dextro-THPB analog, displayed no affinity for the D2 receptor subtype, while its optical isomer, l-THP, was a DA receptor antagonist. This indicates that the levo-optical configuration is necessary for the affinity of THPBs to DA receptors. In addition, l-SPD was 18 times more potent than haloperidol with respect to binding to D1 receptors, but 14 times weaker for D2 receptors. Thus, it is expected that the clinical effects of l-SPD can be distinguished from that of haloperidol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530755

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  20 in total

1.  (-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling.

Authors:  Julie A Meade; R Benjamin Free; Nicole R Miller; Lani S Chun; Trevor B Doyle; Amy E Moritz; Jennie L Conroy; Val J Watts; David R Sibley
Journal:  Psychopharmacology (Berl)       Date:  2014-09-18       Impact factor: 4.530

2.  Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats.

Authors:  John R Mantsch; Samantha Wisniewski; Oliver Vranjkovic; Corey Peters; Amanda Becker; Abbey Valentine; Shi-Jiang Li; David A Baker; Zheng Yang
Journal:  Pharmacol Biochem Behav       Date:  2010-09-09       Impact factor: 3.533

3.  Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.

Authors:  Yazmin Figueroa-Guzman; Christopher Mueller; Oliver Vranjkovic; Samantha Wisniewski; Zheng Yang; Shi-Jiang Li; Colin Bohr; Evan N Graf; David A Baker; John R Mantsch
Journal:  Drug Alcohol Depend       Date:  2010-12-31       Impact factor: 4.492

Review 4.  Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction.

Authors:  Hongyuan Chu; Guozhang Jin; Eitan Friedman; Xuechu Zhen
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

5.  Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study.

Authors:  Zheng Yang; Yong-cong Shao; Shi-jiang Li; Jian-lin Qi; Mei-jie Zhang; Wei Hao; Guo-zhang Jin
Journal:  Acta Pharmacol Sin       Date:  2008-07       Impact factor: 6.150

6.  Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D(1) and antagonist at D(2) receptors, in rats.

Authors:  Yan Sun; Jieyu Dai; Zheyi Hu; Feifei Du; Wei Niu; Fengqing Wang; Fei Liu; Guozhang Jin; Chuan Li
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

7.  Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Hazem E Hassan; Deanna Kelly; Moshe Honick; Sagar Shukla; Ahmed Ibrahim; David A Gorelick; Matthew Glassman; Robert P McMahon; Heidi J Wehring; Ann Marie Kearns; Stephanie Feldman; Mingming Yu; Ken Bauer; Jia Bei Wang
Journal:  J Clin Pharmacol       Date:  2016-08-04       Impact factor: 3.126

8.  Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.

Authors:  Zheng-Xiong Xi; Zheng Yang; Shi-Jiang Li; Xia Li; Christopher Dillon; Xiao-Qing Peng; Krista Spiller; Eliot L Gardner
Journal:  Neuropharmacology       Date:  2007-08-15       Impact factor: 5.250

9.  Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.

Authors:  Wei Fu; Jianhua Shen; Xiaomin Luo; Weiliang Zhu; Jiagao Cheng; Kunqian Yu; James M Briggs; Guozhang Jin; Kaixian Chen; Hualiang Jiang
Journal:  Biophys J       Date:  2007-04-27       Impact factor: 4.033

10.  Inhibitory Effects of Coptidis rhizoma and Berberine on Cocaine-induced Sensitization.

Authors:  Bombi Lee; Chae Ha Yang; Dae-Hyun Hahm; Eun Sang Choe; Hye-Jung Lee; Kwang-Ho Pyun; Insop Shim
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.